Reference : Prevention de l'apparition du diabete de type 2 par l'inhibition du systeme renine-an...
Scientific journals : Article
Human health sciences : Pharmacy, pharmacology & toxicology
Human health sciences : Endocrinology, metabolism & nutrition
http://hdl.handle.net/2268/10593
Prevention de l'apparition du diabete de type 2 par l'inhibition du systeme renine-angiotensine.
French
[en] Prevention of type II diabetes by inhibiting the renin-angiotensin system
Scheen, André mailto [Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale >]
2002
Revue Médicale de Liège
57
7
449-52
Yes (verified by ORBi)
National
0370-629X
Belgium
[en] Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Diabetes Mellitus, Type 1/physiopathology/prevention & control ; Humans ; Hypertension ; Insulin Resistance ; Randomized Controlled Trials as Topic ; Renin-Angiotensin System/drug effects/physiology ; Risk Factors
[en] Type 2 diabetes mellitus and arterial hypertension are part of the insulin resistance syndrome. Besides a metabolic component, insulin resistance has also an haemodynamic component, especially in relation with an endothelial dysfunction. Some studies suggested that inhibitors of angiotensin converting enzyme can improve insulin sensitivity. Interestingly enough, three clinical trials recently reported concordant results showing that the inhibition of the renin-angiotensin system significantly reduces the risk of developing type 2 diabetes in patients at high risk of vascular complications, essentially with hypertension: the CAPPP trial with captopril (-14%, p = 0.39), the HOPE study with ramipril (-34%, p < 0.001) and the LIFE study with losartan (-25%, p < 0.001). However, these observations could be criticized because such a protective effect was only considered as a secondary endpoint in these studies. Two large prospective, controlled, randomized, double-blind trials are ongoing to specifically confirm this interesting hypothesis, one with ramipril and the other with valsartan.
Researchers ; Professionals ; Students
http://hdl.handle.net/2268/10593
http://www.rmlg.ulg.ac.be

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
20020708_06.pdfNo commentaryPublisher postprint437.24 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.